secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aveanna Healthcare Holdings, Inc. (AVAH)
CIK:        0001832332
Form:       8-K
Filed at:   2024-03-14T23:59:59+00:00
Accession:  0000950170-24-031130
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aveanna Q4 revenue up 6.1% to $478.8M; adjusted EBITDA +30.4%; FY2024 guidance issued
--------------------------------------------------------------------------------

- Q4 revenue $478.8M (+6.1% YoY), driven by Private Duty Services and Medical Solutions growth; Home Health & Hospice down slightly.
- Gross margin improved to 31.0% (28.5% a year ago); adjusted EBITDA $38.7M, up 30.4% from $29.7M.
- Net loss narrowed to $25.7M from $237.8M, largely due to a $205.1M goodwill impairment in Q4 2022.
- FY2024 revenue guidance $1.96B–$1.98B; adjusted EBITDA $146M–$150M.
- CEO cites strong Q4 results and momentum from value-based care strategy and enhanced payor partnerships.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832332/000095017024031130/0000950170-24-031130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832332/000095017024031130/avah-20240314.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-031130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer